These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8071691)

  • 21. Positron imaging in dementing illnesses.
    Friedland RP
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):S56-60. PubMed ID: 2535422
    [No Abstract]   [Full Text] [Related]  

  • 22. Interactive three-dimensional region of interest analysis of HMPAO SPECT brain studies.
    Hooper HR; McEwan AJ; Lentle BC; Kotchon TL; Hooper PM
    J Nucl Med; 1990 Dec; 31(12):2046-51. PubMed ID: 2266407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPECT in Alzheimer's disease.
    Lassen NA; Waldemar G
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():188A-189A. PubMed ID: 1498805
    [No Abstract]   [Full Text] [Related]  

  • 24. A method for assessing the significance of abnormalities in HMPO brain SPECT images.
    Houston AS; Kemp PM; Macleod MA
    J Nucl Med; 1994 Feb; 35(2):239-44. PubMed ID: 8294991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain blood flow in the dementias: SPECT with histopathologic correlation.
    Bonte FJ; Tintner R; Weiner MF; Bigio EH; White CL
    Radiology; 1993 Feb; 186(2):361-5. PubMed ID: 8421735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.
    Davis K
    J Nucl Med; 1992 Feb; 33(2):312. PubMed ID: 1732462
    [No Abstract]   [Full Text] [Related]  

  • 27. Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging.
    Hellman RS; Tikofsky RS; Collier BD; Hoffmann RG; Palmer DW; Glatt SL; Antuono PG; Isitman AT; Papke RA
    Radiology; 1989 Jul; 172(1):183-8. PubMed ID: 2787034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral muscarinic receptors in primary degenerative dementia as evaluated by SPECT with iodine-123-labeled QNB.
    Weinberger DR; Mann U; Gibson RE; Coppola R; Jones DW; Braun AR; Berman KF; Sunderland T; Reba RC; Chase TN
    Adv Neurol; 1990; 51():147-50. PubMed ID: 2294653
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuroreceptor mapping with in-vivo imaging techniques: principles and applications.
    Busatto GF; Pilowsky LS
    Br J Hosp Med; 1995 Apr 5-18; 53(7):309-13. PubMed ID: 7788065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new method for brain functional study using Tc-99m HMPAO SPECT.
    Momose T; Kosaka N; Nishikawa J; Ohtake T; Watanabe T; Iio M
    Radiat Med; 1989; 7(2):82-7. PubMed ID: 2798934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography in dementia of the Alzheimer type. A brief review with a case study.
    Berg G; Grady CL; Sundaram M; Haxby JV; Moore AM; White J; Heston L; Rapoport SI; Avioli LV
    Arch Intern Med; 1986 Oct; 146(10):2045-9. PubMed ID: 3490239
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of demented patients by dynamic SPECT of inhaled xenon-133.
    Komatani A; Yamaguchi K; Sugai Y; Takanashi T; Kera M; Shinohara M; Kawakatsu S
    J Nucl Med; 1988 Oct; 29(10):1621-6. PubMed ID: 3262723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMPAO-SPECT imaging resembling Alzheimer-type dementia in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS).
    Grünwald F; Zierz S; Broich K; Schumacher S; Bockisch A; Biersack HJ
    J Nucl Med; 1990 Oct; 31(10):1740-2. PubMed ID: 2213201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The investigation of dementia with single photon emission tomography.
    Buell U; Costa DC; Kirsch G; Moretti JL; van Royen EA; Schober O
    Nucl Med Commun; 1990 Dec; 11(12):823-41. PubMed ID: 2284082
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical correlates of PET- and SPECT-identified defects in dementia.
    Mayberg HS
    J Clin Psychiatry; 1994 Nov; 55 Suppl():12-21. PubMed ID: 7989290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "CORT-EX:" a program for quantitative analysis of brain SPECT data.
    Lamoureux G; Dupont RM; Ashburn WL; Halpern SE
    J Nucl Med; 1990 Nov; 31(11):1862-71. PubMed ID: 2231003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM.
    Kuhl DE; Koeppe RA; Fessler JA; Minoshima S; Ackermann RJ; Carey JE; Gildersleeve DL; Frey KA; Wieland DM
    J Nucl Med; 1994 Mar; 35(3):405-10. PubMed ID: 8113884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data.
    Azari NP; Pettigrew KD; Schapiro MB; Haxby JV; Grady CL; Pietrini P; Salerno JA; Heston LL; Rapoport SI; Horwitz B
    J Cereb Blood Flow Metab; 1993 May; 13(3):438-47. PubMed ID: 8478402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [123I-IMP-SPECT finding of a case of presenile dementia with motor neuron disease--comparison between Alzheimer's disease, Pick's disease and presenile dementia with motor neuron disease].
    Mitsuyama Y
    Seishin Shinkeigaku Zasshi; 1989; 91(7):500-11. PubMed ID: 2608750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An in vivo assessment of the brain in Alzheimer's disease.
    Frohman EM; van den Noort S
    West J Med; 1986 Apr; 144(4):476. PubMed ID: 3487173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.